Differential Expression and Analysis of Peripheral Plasma Exosome miRNA in Patients With Myocardial Infarction
NCT ID: NCT04127591
Last Updated: 2019-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10 participants
OBSERVATIONAL
2019-10-20
2021-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death
NCT06856993
Potential Diagnostic and Prognostic Value of microRNAs for the Patients of Acute Coronary Syndrome
NCT02755207
The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity
NCT00530101
Transcriptome Study of Acute Myocardial Infarction
NCT03158597
The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease
NCT01615003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
myocardial infarction group
Patients admitted with the diagnosis of myocardial infarction.
exosome
Collect exosomes in peripheral blood of patients and extract miRNAs from them.
Blank control group
Patients admitted without the diagnosis of myocardial infarction.
exosome
Collect exosomes in peripheral blood of patients and extract miRNAs from them.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exosome
Collect exosomes in peripheral blood of patients and extract miRNAs from them.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bin He
M.D./Ph.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ethics Committee of Xinhua Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XH-19-010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.